Charlottesville, VA (8 September 2009) : Biovista announced today that it will present at the Marcus Evans 2nd Annual Drug Repositioning and Pipeline Enhancement conference in Philadelphia, PA, Sept. 17-18, 2009. The presentation will cover the advantages of repositioning as a component of portfolio development and lifecycle management, with specific Biovista drug case studies in support.

 Aimed at company pipeline, product and business development managers, the conference will discuss how to implement successful technologies and business models that will enhance life-science companies clinical and commercial output.